Compare TEVA & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | VEEV |
|---|---|---|
| Founded | 1901 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 28.9B |
| IPO Year | N/A | 2013 |
| Metric | TEVA | VEEV |
|---|---|---|
| Price | $33.65 | $183.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 25 |
| Target Price | $37.25 | ★ $293.50 |
| AVG Volume (30 Days) | ★ 7.8M | 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.16 |
| EPS | N/A | ★ 3.96 |
| Revenue | N/A | ★ $1,104,081,000.00 |
| Revenue This Year | N/A | $17.74 |
| Revenue Next Year | $2.97 | $12.28 |
| P/E Ratio | ★ $28.19 | $46.47 |
| Revenue Growth | N/A | ★ 28.05 |
| 52 Week Low | $12.47 | $168.14 |
| 52 Week High | $37.35 | $310.50 |
| Indicator | TEVA | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 42.61 |
| Support Level | $30.70 | $168.14 |
| Resistance Level | $35.32 | $244.69 |
| Average True Range (ATR) | 0.80 | 6.95 |
| MACD | -0.23 | 1.41 |
| Stochastic Oscillator | 18.07 | 70.58 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.